 | Up a level |
Heusser, Peter; Berger, S; Stutz, M; Hüsler, A; Häberli, André; Wolf, Ursula (2009). Efficacy of homeopathically potentized antimony on blood coagulation. A randomized placebo controlled crossover trial. Forschende Komplementärmedizin, 16(1), pp. 14-18. Basel: Karger 10.1159/000196974
Banz, Yara; Hess, Otto M; Robson, Simon C; Csizmadia, Eva; Mettler, Daniel; Meier, Pascal; Haeberli, André; Shaw, Sidney; Smith, Richard A; Rieben, Robert (2007). Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1. Cardiovascular research, 76(3), pp. 482-93. Oxford: Elsevier Ltd. 10.1016/j.cardiores.2007.07.016
Banz, Yara; Hess, Otto M; Robson, Simon C; Mettler, Daniel; Meier, Pascal; Haeberli, André; Csizmadia, Eva; Korchagina, Elena Y; Bovin, Nicolai V; Rieben, Robert (2005). Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury. European Heart Journal, 26(21), pp. 2334-43. Oxford: Oxford University Press 10.1093/eurheartj/ehi421
Vaudaux, Pierre; Pittet, Didier; Häberli, André; Lerch, Peter G.; Morgenthaler, Jean-Jacques; Proctor, Richard A.; Waldvogel, Francis A.; Lew, Daniel P. (1993). Fibronectin Is More Active than Fibrin or Fibrinogen in Promoting Staphylococcus aureus Adherence to Inserted Intravascular Catheters. Journal of infectious diseases, 167(3), pp. 633-641. The University of Chicago Press 10.1093/infdis/167.3.633
Rapold, H. J.; Häberli, A.; Kuemmerli, H.; Weiss, M.; Baur, H. R.; Straub, W. P. (1989). Fibrin formation and platelet activation in patients with myocardial infarction and normal coronary arteries. European Heart Journal, 10(4), pp. 323-333. Oxford University Press 10.1093/oxfordjournals.eurheartj.a059489
Gallino, A.; Häberli, A.; Straub, P. W.; Steinbrunn, W.; Turina, M.; Rothlin, M. E. (1987). Does exercise-induced myocardial ischaemia cause enhanced platelet activation and fibrin formation in patients with stable angina and severe coronary artery disease? European Heart Journal, 8(7), pp. 734-737. Oxford University Press 10.1093/eurheartj/8.7.734
